Aptose Biosciences Inc.

NASDAQ: APTO · Real-Time Price · USD
1.71
0.00 (0.00%)
At close: Apr 01, 2025, 3:59 PM

Aptose Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
6.15M 9.25M 36.97M 39.11M
Short-Term Investments
n/a n/a 9.99M 40.01M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
3.38M 600K 257K 133K
Total Current Assets
9.53M 11.89M 49.52M 81.74M
Property-Plant & Equipment
597K 1.09M 1.51M 788K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
597K 1.09M 1.51M 788K
Total Assets
10.13M 12.99M 51.03M 82.53M
Account Payables
1.26M 3.49M 6.33M 1.7M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
428K n/a n/a n/a
Other Current Liabilities
2.77M n/a 3.36M 3.87M
Total Current Liabilities
4.46M 15.27M 12.28M 8.17M
Long-Term Debt
193K n/a n/a n/a
Other Long-Term Liabilities
9.82M n/a n/a n/a
Total Long-Term Liabilities
10.21M 621K 1M 115K
Total Liabilities
14.67M 15.89M 13.29M 8.29M
Total Debt
621K 1.01M 1.3M 574K
Common Stock
457.4M 444.81M 437.52M 437.39M
Retained Earnings
-540.97M -515.54M -464.33M -422.51M
Comprehensive Income
-4.32M -4.32M -4.32M -4.32M
Shareholders Equity
-4.54M -2.9M 37.74M 74.24M
Total Investments
n/a n/a 9.99M 40.01M